Stephen T. Worland - May 15, 2024 Form 4 Insider Report for eFFECTOR Therapeutics, Inc. (EFTR)

Role
Chief Executive Officer, Director
Signature
/s/ Michael Byrnes, Attorney-in-Fact for Stephen T. Worland
Stock symbol
EFTR
Transactions as of
May 15, 2024
Transactions value $
$3,039
Form type
4
Date filed
5/17/2024, 04:00 PM
Previous filing
Feb 21, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EFTR Common Stock Award $3.04K +1.81K +16.9% $1.68 12.5K May 15, 2024 Direct F1
holding EFTR Common Stock 22.5K May 15, 2024 By trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were acquired under the eFFECTOR Therapeutics, Inc. 2021 Employee Stock Purchase Plan.